G6PD and phenylketonuria: It subsequently became the main laboratory in the country dedicated to newborn screening, which officially commenced in 1973 initially for PKU phenylketonuria and subsequently for G6PD glucose-6-phosphate dehydrogenase deficiency, galactosemia, and hypothyroidism.